Package 72511-479-02

{"route": ["SUBCUTANEOUS"], "spl_id": "51727964-061d-4c73-a22e-0c2e1cd571b0", "openfda": {"nui": ["N0000175610", "N0000175451", "M0001357"], "upc": ["0000000000000", "0372511481020", "0372511482027", "0071100008975", "0372511400014"], "unii": ["FYS6T7F842"], "rxcui": ["2627719", "2627722", "2663901", "2663904", "2663906", "2663907", "2663908", "2663910", "2663914", "2663915"], "spl_set_id": ["b7178e36-6787-45ab-8fee-be59bc6a4aa4"], "pharm_class_cs": ["Antibodies, Monoclonal [CS]"], "pharm_class_epc": ["Tumor Necrosis Factor Blocker [EPC]"], "pharm_class_moa": ["Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "manufacturer_name": ["Amgen USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE in 1 CARTON (72511-479-02)  / .4 mL in 1 SYRINGE", "package_ndc": "72511-479-02", "marketing_start_date": "20241108"}], "brand_name": "AMJEVITA", "product_id": "72511-479_51727964-061d-4c73-a22e-0c2e1cd571b0", "dosage_form": "INJECTION", "pharm_class": ["Antibodies", "Monoclonal [CS]", "Tumor Necrosis Factor Blocker [EPC]", "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "product_ndc": "72511-479", "generic_name": "adalimumab-atto", "labeler_name": "Amgen USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AMJEVITA", "active_ingredients": [{"name": "ADALIMUMAB", "strength": "40 mg/.4mL"}], "application_number": "BLA761024", "marketing_category": "BLA", "marketing_start_date": "20241108", "listing_expiration_date": "20261231"}